Trial intelligence / Profile preview

Efficacy of Ilaprazole on Laryngopharyngeal Reflux Disease and Sleep Quality

KCT0003450Phase 4Completed

Sponsor
Il-Yang Pharmaceutical
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ilaprazole in laryngopharyngeal reflux (LPR), sponsored by Il-Yang Pharmaceutical. Started Feb 2019; status: completed.

02

Drugs

ilaprazole
03

Conditions

laryngopharyngeal reflux (LPR)

Beyond the preview

Go deeper on KCT0003450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call